BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10980777)

  • 1. Subretinal "napkin-ring" membrane in proliferative vitreoretinopathy.
    Tabandeh H; Callejo SA; Rosa RH; Flynn HW
    Arch Ophthalmol; 2000 Sep; 118(9):1287-9. PubMed ID: 10980777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and vitreoretinal management of retinal detachment in eyes with Boston keratoprosthesis.
    Petrou P; Banerjee PJ; Wilkins MR; Singh M; Eastlake K; Limb GA; Charteris DG
    Br J Ophthalmol; 2017 May; 101(5):629-633. PubMed ID: 27565989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inferior retinotomy and silicone oil tamponade for recurrent inferior retinal detachment and grade C PVR in eyes previously treated with pars plana vitrectomy or scleral buckle.
    Mancino R; Aiello F; Ciuffoletti E; Di Carlo E; Cerulli A; Nucci C
    BMC Ophthalmol; 2015 Dec; 15():173. PubMed ID: 26645589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study.
    Scott IU; Flynn HW; Murray TG; Feuer WJ;
    Am J Ophthalmol; 2003 Sep; 136(3):454-63. PubMed ID: 12967798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pars plana lensectomy, pars plana vitrectomy, and silicone oil tamponade as initial management of cataract and combined traction/rhegmatogenous retinal detachment involving the macula associated with severe proliferative diabetic retinopathy.
    Douglas MJ; Scott IU; Flynn HW
    Ophthalmic Surg Lasers Imaging; 2003; 34(4):270-8. PubMed ID: 12875454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-silicone oil injection of methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy.
    Ghasemi Falavarjani K; Modarres M; Hadavandkhani A; Karimi Moghaddam A
    Eye (Lond); 2015 Sep; 29(9):1199-203. PubMed ID: 26160528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal redetachment after removal of intraocular silicone oil tamponade.
    Jonas JB; Knorr HL; Rank RM; Budde WM
    Br J Ophthalmol; 2001 Oct; 85(10):1203-7. PubMed ID: 11567965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-speed, high-resolution spectral optical coherence tomography in patients after vitrectomy with internal limiting membrane peeling for proliferative vitreoretinopathy retinal detachment.
    Odrobina DC; Michalewska Z; Michalewski J; Nawrocki J
    Retina; 2010 Jun; 30(6):881-6. PubMed ID: 20182404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathological examination of 10 eyes with silicone oil injection].
    Wang W; Zhang H; Schilling H
    Zhonghua Yan Ke Za Zhi; 1996 Jul; 32(4):295-7. PubMed ID: 9590849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of neural progenitor cells in human eyes with proliferative vitreoretinopathy.
    Johnsen EO; Frøen RC; Albert R; Omdal BK; Sarang Z; Berta A; Nicolaissen B; Petrovski G; Moe MC
    Exp Eye Res; 2012 May; 98():28-36. PubMed ID: 22465407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemistry of cellular proliferation in eyes with longstanding retinal detachment.
    Mietz H; Stödtler M; Wiedemann P; Heimann K
    Int Ophthalmol; 1994-1995; 18(6):329-37. PubMed ID: 7642333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinotomy and silicone oil for detachments complicated by anterior inferior proliferative vitreoretinopathy.
    Tsui I; Schubert HD
    Br J Ophthalmol; 2009 Sep; 93(9):1228-33. PubMed ID: 19429589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial.
    Ahmadieh H; Feghhi M; Tabatabaei H; Shoeibi N; Ramezani A; Mohebbi MR
    Ophthalmology; 2008 Nov; 115(11):1938-43. PubMed ID: 18584876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anatomical and visual outcomes after two-port pars plana vitrectomy reoperation under silicone oil for epimacular membrane or recurrent retinal detachment.
    Sigler EJ; Randolph JC; Calzada JI; Charles S
    Retina; 2014 Oct; 34(10):1939-44. PubMed ID: 24776639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical study on vitrectomy specimens of proliferative retinal diseases].
    Cao J; Wu L; Zhang H
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):264-7. PubMed ID: 10451957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of retinotomy for retinal redetachment in the silicone oil filled eye].
    Nawrocki J; Starska D
    Klin Oczna; 2002; 104(1):30-2. PubMed ID: 12046306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytological study of subretinal fluid].
    Xu X; He Z
    Zhonghua Yan Ke Za Zhi; 1997 Nov; 33(6):450-2. PubMed ID: 10680550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental tractional retinal detachment: an immunohistochemical study.
    Basmak H; Isiksoy S; Topbas S; Artan S; Yurdakul S
    Eur J Ophthalmol; 1998; 8(2):112-7. PubMed ID: 9673481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of relaxing retinotomy on surgical outcomes in proliferative vitreoretinopathy.
    Tseng JJ; Barile GR; Schiff WM; Akar Y; Vidne-Hay O; Chang S
    Am J Ophthalmol; 2005 Oct; 140(4):628-36. PubMed ID: 16226515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAINING-ASSISTED REMOVAL OF SILICONE OIL FOR THE IDENTIFICATION OF SUBCLINICAL PROLIFERATIVE VITREORETINOPATHY.
    Rizzo S; Barca F; Faraldi F; Caporossi T; Virgili G
    Retina; 2017 Nov; 37(11):2118-2123. PubMed ID: 28045788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.